PubRank

Paul A Price

Author PubWeight™ 43.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 2007 2.69
2 Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 2006 1.74
3 Systematic analysis of cyclic di-GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis. Mol Microbiol 2010 1.44
4 The size exclusion characteristics of type I collagen: implications for the role of noncollagenous bone constituents in mineralization. J Biol Chem 2007 1.44
5 High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 2003 1.42
6 YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002 1.29
7 Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 2006 1.24
8 Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009 1.24
9 High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003 1.21
10 Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 2003 1.18
11 High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 2002 1.18
12 YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem 2007 1.10
13 High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004 1.10
14 High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol Rep 2003 1.09
15 Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008 1.08
16 The optical afterglow of the short gamma-ray burst GRB 050709. Nature 2005 1.06
17 Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J Clin Oncol 2008 1.05
18 Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo) 2009 1.04
19 Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog 2013 1.04
20 Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002 1.00
21 Is YKL-40 a new therapeutic target in cancer? Expert Opin Ther Targets 2007 1.00
22 Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008 1.00
23 Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler Thromb Vasc Biol 2006 0.98
24 Minerals form a continuum phase in mature cancellous bone. Calcif Tissue Int 2011 0.97
25 YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer 2009 0.97
26 YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. Breast Cancer Res Treat 2007 0.96
27 YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007 0.93
28 Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet Gynecol Scand 2003 0.93
29 Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am J Pathol 2009 0.93
30 Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Clin Cancer Res 2007 0.93
31 The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int 2007 0.92
32 Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med 2004 0.91
33 Posttranscriptional regulation of the Yersinia pestis cyclic AMP receptor protein Crp and impact on virulence. MBio 2014 0.90
34 Plasma YKL-40 and total and disease-specific mortality in the general population. Clin Chem 2010 0.90
35 High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int J Cancer 2008 0.89
36 Identification of an osteocalcin isoform in fish with a large acidic prodomain. J Biol Chem 2006 0.87
37 Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study. J Bone Miner Res 2009 0.86
38 YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 2007 0.82
39 Structural evidence of a fourth Gla residue in fish osteocalcin: biological implications. Biochemistry 2005 0.81
40 Evolution of matrix and bone gamma-carboxyglutamic acid proteins in vertebrates. J Biol Chem 2005 0.80
41 Sturgeon osteocalcin shares structural features with matrix Gla protein: evolutionary relationship and functional implications. J Biol Chem 2013 0.77
42 Teleost fish osteocalcin 1 and 2 share the ability to bind the calcium mineral phase. Fish Physiol Biochem 2013 0.75